Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited (TLX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
tlx · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$17.00
Consensus
$17.00
+81.2% upside
Low
$17.00
Median: $17 · Last Close: $9.38
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.97 | ↓ 4.40% |
1-day model range: $8.92–$9.02. Peak: $9.02 (-4.40%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | -40.0% |
| 2028 | $4 | -54.4% |
| 2029 | $4 | -61.0% |
| 2030 | $3 | -64.3% |
| 2031 | — | -66.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TLX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-13 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-07 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-24 | Citigroup | Maintains | Buy→Buy |
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-23 | UBS | Maintains | Buy→Buy |
| 2025-09-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-28 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Telix Pharmaceuticals Limited (TLX) stock. Of the recent 13 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover TLX.
Analyst Recommendation Trends
TLX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.4B
↓ 26.9% YoY
Revenue Next Year
$1.7B
↑ 17.4% YoY
EPS This Year
$0.06
EPS Next Year
$0.15
↑ 160.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast TLX EPS of $0.06 for the current fiscal year, based on estimates from 6 analysts. The TLX revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TLX stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TLX price target is $17.00 (+81.2% upside), with an analyst consensus of Buy.
The TLX short-term stock prediction for tomorrow is $8.97 (-4.40%). The TLX stock price prediction for 2027 estimates an average of $6. The TLX stock prediction for 2030 projects a range of $3–$4.
Telix Pharmaceuticals Limited trades on NASDAQ under the ticker TLX. The TLX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
TLX forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month TLX price target is $17.00, with a high forecast of $17.00 and a low of $17.00. The median price target is shown in the chart above when available. This implies +81.2% potential upside from the current price of $9.38.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.